Home Authors Posts by Dominic Cuthbert

Dominic Cuthbert

PPMA – event – sep 2018

Latest news

Pfizer’s sNDA for Xtandi gets priority review for prostate cancer

Pfizer and Astellas Pharma have obtained priority review status from the US Food and Drug Administration (FDA) for the supplemental new drug application (sNDA)...

Helsinn to purchase skin cancer drug Valchlor from Actelion

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, has entered into a definitive agreement to acquire worldwide rights to Valchlor®/Ledaga®, (mechlorethamine/chlormethine)...

Sun Pharma Announces U.S. FDA Approval of ILUMYA™

Sun Pharmaceutical Industries has announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe...